Palisade Bio PALI
NASDAQ PALI
$1.43 +0.08 (+5.93%)
At close: Oct 1, 2026 · 4:00 PM EDT

Palisade Bio (PALI) Return on Equity [ROE] (2011 - 2026)

Updated

Palisade Bio's Return on Equity [ROE] came in at -28.39% for Q2 2026, up 276.98 percentage points from -305.37% a year earlier but down 7.74 percentage points from the prior quarter.

Analysis

Palisade Bio (PALI) Return on Equity [ROE] (2011 - 2026) Analysis & Trends

For FY2025, Palisade Bio's Return on Equity [ROE] was -26.40%, up 131.76 percentage points from FY2024.

  • Return on Equity [ROE] carries a three-year change of +132.18 percentage points (FY2022 to FY2025).
  • Going back by year, Return on Equity [ROE] was -158.16% in FY2024 (-48.17 pp), -109.99% in FY2023 (+48.58 pp) and -158.58% in FY2022.
  • The five-year range for quarterly Return on Equity [ROE] is -784.19% (Q4 2021) to -20.65% (Q1 2026).
  • Year-over-year, Return on Equity [ROE] has increased for three consecutive quarters, with an average year-over-year change of +0.88 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2022 (a gain of 657.86 percentage points), and the weakest in Q3 2025 (a drop of 216.39 percentage points).
  • Business Quant data shows PALI's Return on Equity [ROE] at -20.65% (Q1 2026), -27.25% (Q4 2025) and -393.28% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Palisade Bio 234.35 Mn -162.09 Mn - -28.39%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -28.39%
Mar 31, 2026 -20.65%
Dec 31, 2025 -27.25%
Sep 30, 2025 -393.28%
Jun 30, 2025 -305.37%
Mar 31, 2025 -210.68%
Dec 31, 2024 -210.94%
Sep 30, 2024 -176.89%
Jun 30, 2024 -148.21%
Mar 31, 2024 -133.13%
Dec 31, 2023 -103.05%
Sep 30, 2023 -92.22%
Jun 30, 2023 -97.53%
Mar 31, 2023 -109.62%
Dec 31, 2022 -126.33%
Sep 30, 2022 -191.27%
Jun 30, 2022 -323.00%
Mar 31, 2022 -731.69%
Dec 31, 2021 -784.19%
Sep 30, 2019 -182.85%
API Access

Palisade Bio Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PALI&period=max&api_key=YOUR_API_KEY